Are we Ready for Controlling Community Transmission of COVID 19 in India?

  • Vidya Jha Assistant Professor, Asst. Medical Administrator, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham University, Cochin, Kerala, India. https://orcid.org/0000-0001-7524-3566
  • Dinesh TA Professor & HOD, Master of Hospital Administration, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham University, Cochin, Kerala, India.
  • Prem Nair Professor, Department of Hospital Administration, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham University, Cochin, Kerala, India.
Keywords: COVID-19, Diagnostic Tests, Social Distancing, Community Transmission

Abstract

The globe is witnessing COVID-19 pandemic and in India the confirmed cases are increasing day by day. Impact of limits on diagnostic testing in Indian population (1.38 billion) and on controlling the COVID-19 outbreak will be huge. These issues can be mitigated up to a certain limit by increased availability of diagnostic tests or the use of a point-of-care diagnostic test. The buzz word is “Social distancing” and over 63% of the population should practice it to make it effective. If appropriate measures are not taken, all hospital beds will be occupied in the coming 1-2 months and there will be shortage of Personal protective equipment and masks for healthcare workers. Are we doing enough to protect our healthcare workers? Are we ready to control community transmission of COVID-19 in India?

References

https://www.worldometers.info/coronavirus/#countries.

https://www.wired.co.uk/article/uk-coronavirusspread-app-phone-data.

https://www.indiatoday.in/india/story/rajasthan-18-coronavirus-patients-including-15-doctors-bhilwaracontinues-battle-covid-19-1660064-2020-03-26.

Wang D, Bo Hu, Chang Hu, Fangfang Zhu, Xing Liu et al. Clinical Characteristics of 138 Hospitalized Patients

With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA.2020;323(11):1061-1069.

doi:10.1001/jama.2020.1585.

htt ps : / / w w w.fd a . gov / n ews - eve nt s / p re s s -announcements/coronavirus-covid-19-update-fdaissues-

first-emergency-use-authorization-point-carediagnostic.

https://www.mohfw.gov.in/pdf/NotificationofICMguidelinesforCOVID19testinginprivatelaboratoriesiI

ndia.pdf.

Guan WJ, Ni ZY, Hu Y et al. China Medical TreatmentExpert Group for Covid-19. Clinical characteristics of

coronavirus disease 2019 in China. N Engl J Med. 2020.doi:10.1056/NEJMoa2002032.

Published
2020-03-28